Anterior ischemic optic neuropathy (AION) occurs when there is not enough blood flow into the eye. This causes damage to the optic nerve, quickly leading to vision loss. There are two subtypes of AION ...

Please provide your email address to receive an email when new articles are posted on . The deep learning system demonstrated an AUC of 0.97, a sensitivity of 91.1%, a specificity of 93.4% and an ...

Nonarteritic, anterior ischemic optic neuropathy is the most common form of ischemic optic neuropathy. 3,4 Typical presentation includes acute, unilateral, and painless loss of central and/or ...

Worsening of vision occurred within a few weeks after onset of symptoms in most eyes with nonarteritic anterior ischemic optic neuropathy (NAION) that progressed. Only a past episode in the other eye, ...

Patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) appear to have a very low incidence of nonarteritic anterior ischemic optic neuropathy (NAION) when appropriately prescribed ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults prescribed semaglutide were more likely to ...

Semaglutide was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in adults with type 2 diabetes. The risk was more modest than previously reported. Using the specific ...

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and ...

The EMA’s safety committee has issued a warning that the GLP-1 receptor agonist Ozempic (semaglutide, Novo Nordisk A/S) can cause an acute eye condition in which the optic nerve is damaged by a sudden ...

People with type 2 diabetes starting semaglutide have more than a doubled risk for NAION versus those starting SGLT2is.